Related references
Note: Only part of the references are listed.Division of labor in collaborative knowledge production: The role of team size and interdisciplinarity
Carolin Haeussler et al.
RESEARCH POLICY (2020)
Prepublication disclosure of scientific results: Norms, competition, and commercial orientation
Jerry G. Thursby et al.
SCIENCE ADVANCES (2018)
Found in Translation : How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax
Joel D. Leverson et al.
CANCER DISCOVERY (2017)
Changing R&D models in research-based pharmaceutical companies
Alexander Schuhmacher et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials
Cornelis A. van den Bogert et al.
PLOS ONE (2016)
Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers
Ayfer Ali et al.
RESEARCH POLICY (2016)
Beneficiary contact and innovation: The relation between contact with patients and medical innovation under different institutional logics
Oscar Llopis et al.
RESEARCH POLICY (2016)
Basic science as a prescription for breakthrough inventions in the pharmaceutical industry
Antonio Della Malva et al.
JOURNAL OF TECHNOLOGY TRANSFER (2015)
The Renaissance Man is not dead! The role of generalists in teams of inventors
Eduardo Melero et al.
RESEARCH POLICY (2015)
Pharmaceutical R&D Performance by Firm Size: Approval Success Rates and Economic Returns
Joseph A. DiMasi
AMERICAN JOURNAL OF THERAPEUTICS (2014)
Balancing breadth and depth of expertise for innovation: A 3M story
Wai Fong Boh et al.
RESEARCH POLICY (2014)
Conflicting Logics? A Multidimensional View of Industrial and Academic Science
Henry Sauermann et al.
ORGANIZATION SCIENCE (2013)
The Geographical Distribution of Leadership in Globalized Clinical Trials
Jarno Hoekman et al.
PLOS ONE (2012)
Inventors and entrepreneurs in academia: What types of skills and experience matter?
Pablo D'Este et al.
TECHNOVATION (2012)
The immuno-oncology framework Enabling a new era of cancer therapy
Axel Hoos et al.
ONCOIMMUNOLOGY (2012)
Digital Science and Knowledge Boundaries in Complex Innovation
Deborah Dougherty et al.
ORGANIZATION SCIENCE (2012)
Getting Competition Down to a Science: The Effects of Technological Competition on Firms' Scientific Publications
Francisco Polidoro et al.
ORGANIZATION SCIENCE (2012)
The productivity crisis in pharmaceutical R&D
Fabio Pammolli et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Lesley Seymour et al.
CLINICAL CANCER RESEARCH (2010)
LEVERAGING INTERNAL AND EXTERNAL EXPERIENCE: EXPLORATION, EXPLOITATION, AND R&D PROJECT PERFORMANCE
Ha Hoang et al.
STRATEGIC MANAGEMENT JOURNAL (2010)
Progress and Deficiencies in the Registration of Clinical Trials
Alastair J. J. Wood
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Burden of Knowledge and the Death of the Renaissance Man: Is Innovation Getting Harder?
Benjamin F. Jones
REVIEW OF ECONOMIC STUDIES (2009)
Does focus improve operational performance? Lessons from the management of clinical trials
Robert S. Huckman et al.
STRATEGIC MANAGEMENT JOURNAL (2008)
Virtuous circles in science and commerce
Lynne G. Zucker et al.
PAPERS IN REGIONAL SCIENCE (2007)
The Cost of Biopharmaceutical R&D: Is Biotech Different?
Joseph A. DiMasi et al.
MANAGERIAL AND DECISION ECONOMICS (2007)
Translational research: Moving discovery to practice
E. A. Zerhouni
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Experience and scale and scope economies: Trade-offs and performance in development
Jeffrey T. Macher et al.
STRATEGIC MANAGEMENT JOURNAL (2006)
The major role of clinicians in the discovery of off-label drug therapies
HJ DeMonaco et al.
PHARMACOTHERAPY (2006)
Estimating the cost of new drug development: Is it really $802 million?
CP Adams et al.
HEALTH AFFAIRS (2006)
Opinion - Anticipating change in drug development: the emerging era of translational medicine and therapeutics
GA FitzGerald
NATURE REVIEWS DRUG DISCOVERY (2005)
Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances
PM Danzon et al.
JOURNAL OF HEALTH ECONOMICS (2005)
Transferring, translating, and transforming: An integrative framework for managing knowledge across boundaries
PR Carlile
ORGANIZATION SCIENCE (2004)
Science as a map in technological search
L Fleming et al.
STRATEGIC MANAGEMENT JOURNAL (2004)
Capturing knowledge within and across firm boundaries: Evidence from clinical development
P Azoulay
AMERICAN ECONOMIC REVIEW (2004)
Sharing meaning across occupational communities: The transformation of understanding on a production floor
BA Bechky
ORGANIZATION SCIENCE (2003)
Central challenges facing the national clinical research enterprise
NS Sung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Industry-sponsored clinical research: a double-edged sword
JSG Montaner et al.
LANCET (2001)
Entrepreneurship in the large corporation: A longitudinal study of how established firms create breakthrough inventions
G Ahuja et al.
STRATEGIC MANAGEMENT JOURNAL (2001)
Beyond local search: Boundary-spanning, exploration, and impact in the optical disk industry
L Rosenkopf et al.
STRATEGIC MANAGEMENT JOURNAL (2001)
Making the next move: How experiential and vicarious learning shape the locations of chains' acquisitions
JAC Baum et al.
ADMINISTRATIVE SCIENCE QUARTERLY (2000)
An analysis of the critical role of public science in innovation: the case of biotechnology
GS McMillan et al.
RESEARCH POLICY (2000)
Share Paper
